FDA Approved: NABUMETONE — Supplemental Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a supplemental application for Nabumetone from ScieGen Pharmaceuticals Inc, resulting in updated labeling and potential new indications for the dru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Nabumetone (Nabumetone)

Snippet

SUPPL AP for NABUMETONE (NABUMETONE)